Initiator Pharma A/S
INIT
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -3.80 | -57.24% |
| 2025 | -8.88 | -53.65% |
| 2024 | -19.16 | -99.86% |
| 2023 | -14.14K | 277,318,398.04% |
| 2022 | -0.01 | -47.96% |
| 2021 | -0.01 | -12.50% |
| 2020 | -0.01 | -32.53% |
| 2019 | -0.02 | 260.87% |
| 2018 | 0.00 | 187.50% |
| 2017 | 0.00 | -100.00% |
| 2016 | -47.23 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| -8.15 | 114.52% |
US
|
|
| 34.39 | -1,005.73% |
US
|
|
| -31.59 | 732.01% |
US
|
|
| -25.99 | 584.31% |
AU
|
|
| 25.67 | -776.03% |
BE
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.
Questions about Initiator Pharma A/S's P/E ratio
What is Initiator Pharma A/S's P/E ratio?
Initiator Pharma A/S's P/E ratio is -3.80, as of Nov 2026.
What was Initiator Pharma A/S's P/E ratio in 2025?
In 2025, Initiator Pharma A/S's P/E ratio was -8.88, compared with -19.16 in 2024.
How has Initiator Pharma A/S's P/E ratio changed since 2020?
From 2020 to 2025, Initiator Pharma A/S's P/E ratio was highest in 2022 (-0.01) and lowest in 2023 (-14.14K).
How does Initiator Pharma A/S's P/E ratio compare with similar companies?
Initiator Pharma A/S's P/E ratio (-3.80) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 34.39.